Collectively, our results demonstrate that VPA selectively exerts anti-tumor activity in vitro through induction of growth inhibition as well as apoptosis in the EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer cells. The gene discussed is ERBB2; the disease is familial pancreatic carcinoma.